Emmaus Life Sciences Inc (PK:EMMA)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 14th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 29/24 Feb 29/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 77,000 $0.130
Feb 29/24 Feb 28/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 15,000 $0.120
Feb 29/24 Feb 27/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 10,000 $0.130
Feb 29/24 Feb 26/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 13,200 $0.120
Feb 5/24 Feb 1/24 Zwicker Ian Harvey Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 ZEN Wei Peu Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 Lim Seah H. Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 Stark Charles William Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Feb 5/24 Feb 1/24 Sekulich George Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Feb 5/24 Feb 1/24 Nagasaki Yasushi Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 14th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 29/24 Feb 29/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 77,000 $0.130
Feb 29/24 Feb 28/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 15,000 $0.120
Feb 29/24 Feb 27/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 10,000 $0.130
Feb 29/24 Feb 26/24 Lee Willis C Indirect Ownership Common stock, $0.001 par value P - Open market or private purchase 13,200 $0.120
Feb 5/24 Feb 1/24 Zwicker Ian Harvey Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 ZEN Wei Peu Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 Lim Seah H. Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 100,000 $0.150
Feb 5/24 Feb 1/24 Stark Charles William Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Feb 5/24 Feb 1/24 Sekulich George Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Feb 5/24 Feb 1/24 Nagasaki Yasushi Direct Ownership Options A - Grant, award or other under Rule 16b-3(d) 200,000 $0.150
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $EMMA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.